Latam Airlines Group Sa【LTM】株式ニュース | ADVFN

US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
アメリカ
NYSE
Latam Airlines Group Sa (LTM)
Latam Airlines Group Sa (LTM) ニュース

Latam Airlines Group Sa (LTM)

27.00

-0.02

(-0.07%)

終値： 11月13日 6:00AM

27.00

0.00

( 0.00% )

取引時間後: 6:00AM

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Rio Tinto to acquire Arcadium Lithium

World-class lithium business to strengthen Rio Tinto’s position as global leader in energy transition commodities Counter-cyclical expansion...

LATAM to Host Investor Day on October 22, 2024 in New York

LATAM to Host Investor Day on October 22, 2024 in New York PR Newswire SANTIAGO, Chile, Oct. 7, 2024 SANTIAGO, Chile, Oct. 7, 2024 /PRNewswire/...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM ...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM ...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM ...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM ...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM ...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM ...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K...

The_Gman

The_Gman 4分前

Space. The difference between witnessing a kid napping....and a kidnapping.

Yeah, that's where the pic came from.

ignatiusrielly35

ignatiusrielly35 4分前

You have no information as to when specifically the ATM is used. Period. In fact, I recall you attributing a price dip earlier this year to dilution in one quarter and the 10q showed virtually none. I repeat, blind guess.

12yearplan

12yearplan 4分前

Sorry for the late reply; .. from your two links and thanks..

Summary.

Since the early 1970s, hourly inflation-adjusted wages received by the typical worker have barely risen, growing only 0.2% per year. Assigning relative responsibility to the policies and economic f

navycmdr

navycmdr 4分前

https://x.com/InvestIt3/status/1856406733754708460

2B_unknown

2B_unknown 5分前

Yes, we have had the golden ticket for some time now:)

We got this thing, just a matter of time.

Hosai

From what I can see based on historical EMA review start dates in late 22 and 23 and aided by chat GPT it guesses the last 2 EMA review start dates for 2024 will be Nov 28th and Dec 27th.
If Anavex were to be aiming for the Nov 28th (ish) it would need to submit any time now. Obv though even

MartinLutherKing

MartinLutherKing 5分前

It just hit the wires brother
https://www.forbes.com/sites/jessicaourisman/2024/11/12/the-firsthand-results-of-a-nanofat-treatment-using-stem-cells-and-prp/

manibiotech

manibiotech 5分前

Yep nothing for market to be in any FOMO mode
Likely will slowly go down over next few days without news . As I also said after ASM

Groveman1

Groveman1 5分前

Lucky, There's a new response on StockRunners twitter site today 11/12/24 on LLBO. Please check it and see if you can understand what this means for LLBO. StockRunners talks about attorneys and filing papers, but seems to be speaking about the other Company attached to the Post. Check it out.

FeMike

I think they would rather say the inspection is completed even if the 10-q is up to September 30 only. If it's done by now since the q was prepared this nov. Therefore, it is not completed up to now.

My personal opinion is that saying "the inspections have been completed" is a bit too

cottonisking

cottonisking 6分前

No, peanuts and small money, compared to this board waiting here since 2008 and going through United States' Presidents and nut cases. Shut this mental ward down now. These guys have nothing better to do. Most must be in their 80s.

northam43

northam43 6分前

Report #2 October 2024 SPX Cycles

https://investorshub.advfn.com/uimage/uploads/2024/11/12/inz[o2_Completed_Cycles.PNG

manibiotech

manibiotech 7分前

Look at section subsequent events in 10 q

Hmm

jimr1717

jimr1717 7分前

New Tesla Involved in a Crash While on FSD, the Teslacam Footage Was All Police Needed
3 Nov 2024, 22:00 UTC •

Bob claims that the moment the pickup truck slammed into his rear end, the FSD turned the steering wheel to the left to prevent his Tesla from hitting the vehicle wait

MRJ25

Reddit will be better.

Rebel13

Rebel13 7分前

There’s a saying about not being able to find your a$$ even if handed to you. Didn’t realize you were real!

art2426

art2426 8分前

We're not getting into politics? Really? Who exactly brought THIS up? ---- "Especially with the new pro small business President we just elected!"

How is reading this board, NOT FUN?

jimr1717

jimr1717 8分前

How? Watch and learn.

mrwrn2010

mrwrn2010 9分前

Blast from the past!

Mactheriverrat

Mactheriverrat 9分前

Thoughts on TLRY?

exwannabe

exwannabe 9分前

Reimbursement. The Company has evaluated and selected specialized, highly experienced consultants with whom to undertake preparations for a potential reimbursement review ...
In other words, not even close to submitting the evidence that kicks off the NICE process.

gdog

11-12 buy/cover EVH $14.19 + 4.15%

MahinAgency

MahinAgency 10分前

H.C. Wainwright maintains a "Buy" rating for Cardiol Therapeutics with a price target of $9.00.

MAVERIC-2 trial aims to assess CardiolRx in recurrent pericarditis patients post-IL-1 blocker therapy.

againstallodds

againstallodds 10分前

Market expects gold delivery, imagine if no delivery

No gold = no created value

CommodityCoverage

CommodityCoverage 10分前

Developing therapeutic compounds for pediatric diseases with unmet medical needs and a large addressable market, clinical-stage biotech company Thiogenesis Therapeutics (TTI.v), recently announced the approval of its European patent for the treatment of Cysteamine Sensitive Disorders, a medical cond

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約